PGT Genetic Testing: Legal Restrictions by Country (PGT-M, PGT-SR and PGT-A)

Preimplantation genetic testing (PGT) means testing embryos created through IVF before one is chosen for transfer. Lawmakers don't treat all PGT the same way. Testing an embryo for a serious inherited disease that runs in your family is regulated very differently from screening embryos for chromosome counts, and both are treated differently from choosing an embryo's sex. If you are travelling because a test is restricted at home, or you are choosing a destination and need a particular test, this guide explains how the legal picture breaks down.

The three kinds of PGT

PGT-M and PGT-SR are diagnostic: they look for something specific with a known family risk. PGT-A is screening. That difference largely explains why many countries allow the first two while restricting the third.

Europe: what is permitted where

The most complete comparison of European rules is ESHRE's survey of assisted reproduction legislation in 43 countries, describing the position at 31 December 2020 (ESHRE EIM survey, Human Reproduction, 2024). It found:

TestNot permitted inWhat this means for you
PGT-M and PGT-SRBosnia and Herzegovina (Republika Srpska), Iceland, Luxembourg, SerbiaDiagnostic testing is widely available elsewhere in Europe, usually subject to conditions
PGT-ABosnia and Herzegovina (Republika Srpska), Denmark, France, Hungary, Iceland, Lithuania, Luxembourg, the Netherlands, Norway, SwedenPatients from these countries who want PGT-A have to go elsewhere for it
Sex selection without a medical reasonPossible only in Armenia among the countries surveyedElsewhere, sex is selected only to avoid a sex-linked disease

One detail: the survey's summary gives three countries as not allowing PGT-M/SR, but the main text names four. The table follows the main text. Whatever the count, check the current position in your chosen country, because rules may have changed since 2020.

How individual countries regulate PGT

Spain: permitted purposes plus authorisation

Spain's Law 14/2006 lets licensed centres test embryos for two purposes. One is to detect serious hereditary diseases that start early and have no cure after birth, so that unaffected embryos can be chosen. The other is to detect abnormalities that could affect an embryo's viability (Law 14/2006, BOE). These cases must be reported to the health authority. Any other use needs express, case-by-case authorisation, with a favourable report from the National Commission on Assisted Human Reproduction. Sex selection or genetic manipulation for non-therapeutic purposes is a very serious infraction, with fines of up to €1,000,000.

So if a serious family condition fits the statute's categories, the clinic reports the case and goes ahead. A purpose outside those categories means a formal application, which can delay your cycle.

United Kingdom: a conditions list and an evidence rating

The HFEA publishes a list of PGT-M conditions for clinics, so whether a condition is on it is the first thing to check. PGT-A sits under the HFEA's treatment add-ons system. It is rated red, meaning there are potential safety concerns and/or evidence that it may reduce the effectiveness of treatment (HFEA add-ons ratings, reviewed 2026). PGT-A isn't banned in the UK. The rating is the regulator's view of the evidence, which patients should weigh before paying for it anywhere.

Countries that don't permit PGT-A

Denmark, France, the Netherlands, Norway and Sweden aren't otherwise restrictive on fertility treatment. Their PGT-A limits reflect concerns about one specific technique. If you live in one of them and are thinking of going abroad for PGT-A, it's worth asking why your own system decided against it. The HFEA's red rating suggests the caution isn't unique to those countries.

Outside Europe

We couldn't verify comparable country-by-country PGT rules for Latin America or the US in the sources reviewed for this guide. For any destination outside the ESHRE survey, ask the clinic which law or regulator governs embryo testing, and whether any test needs prior approval.

Match your situation to the right legal question

Your situationTest involvedLegal question to ask the destination
A known single-gene condition in you or your partnerPGT-MIs this condition within the permitted purposes or an approved list? Is prior authorisation needed?
A balanced translocation or other rearrangement in one parentPGT-SRIs PGT-SR permitted, and are the same conditions applied as for PGT-M?
Concern about chromosome abnormalities, with no known family conditionPGT-AIs PGT-A permitted at all? If so, what does the clinic say about the evidence, given the HFEA's red rating?
A sex-linked disease in the familyPGT-MIs choosing the embryo's sex allowed for this medical reason, and how is it documented?

When tested embryos have to travel home

Some patients do the test abroad and plan the transfer at home. If your home country doesn't permit the test you had, don't assume your home clinic will accept and transfer the embryos. Ask before treatment starts, and get the answer in writing, along with any documents it will need about the testing. Planning the shipment comes after that. The legal question has to be settled first.

What "legal" doesn't tell you

A test being allowed doesn't mean it is done well. Things the law usually leaves open:

Our guide to what to verify before paying for PGT-A abroad covers the lab and reporting questions in detail.

If you need PGT-M abroad: a checklist

  1. Get a genetic report confirming the exact variant in the affected parent, and share it with the clinic before booking.
  2. Check that your condition is covered. Confirm that it falls within the destination's permitted purposes, or within an approved list where one exists.
  3. Ask whether an authorisation step applies. In Spain, purposes outside the statute need a case-by-case authorisation. Build that time into your plan.
  4. Ask about test development. Find out whether family samples are needed and how long the work-up takes before your IVF cycle can start.
  5. Plan for genetic counselling before and after testing, in a language you are comfortable with.
  6. Agree what happens to affected embryos and record it in your consent forms.

What to bring to the first consultation

About "family balancing" offers: some clinics advertise sex selection for non-medical reasons. ESHRE found that among the 43 European countries surveyed, only Armenia allowed it. In Spain it is a very serious infraction. If a clinic offers it, check whether the treatment country allows it, and consider your home country's laws on medical treatment abroad.

Testing and storage go together

PGT usually means freezing embryos while you wait for results, which brings storage rules into play. Spain requires consent for stored embryos to be renewed at least every two years. Other countries set their own time limits. If you are testing abroad and may transfer later or elsewhere, read our guide to embryo storage duration limits by country before you start. For the wider legal picture, our overview of legal considerations for IVF abroad may help.

Ready to Take Next Steps?

If you need embryo testing, check what your chosen country allows before you compare clinics. Explore Colombia's fertility clinics and resources, or schedule a telemedicine consultation to discuss your specific situation.

Frequently Asked Questions: PGT Legal Restrictions

Is PGT-A legal everywhere in Europe?

No. ESHRE's survey found PGT-A not permitted in 10 countries, including Denmark, France, the Netherlands, Norway and Sweden, as of the end of 2020. In most other countries it was not prohibited, though availability and evidence vary. Confirm the current rules for your destination.

Why is PGT-M allowed in more places than PGT-A?

PGT-M tests for a specific inherited condition with a known risk in the family, so its purpose is clear. PGT-A screens embryos without a specific known risk, and regulators disagree about its benefit. The UK's HFEA, for example, rates PGT-A red in its add-ons system.

Can I choose my baby's sex through PGT abroad?

Among the European countries ESHRE surveyed, sex selection without a medical reason was possible only in Armenia. Spain treats it as a very serious infraction. Selection to avoid a sex-linked disease is a separate, medical use that many countries allow under their PGT-M rules.

Does my condition need approval before PGT-M in Spain?

Spanish law allows testing for serious early-onset hereditary diseases with no cure after birth, and for abnormalities affecting embryo viability. A purpose outside those needs case-by-case authorisation, with a report from the national commission. Ask the clinic whether your condition falls within the permitted purposes.

If PGT is legal in a country, is every clinic's testing reliable?

Not necessarily. The law sets what is allowed, not how well it is done. Ask which lab analyses the biopsies, whether it is accredited, how unclear results are handled and whether you will get the full lab report.